Sunovion Respiratory Development Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$100M
Sunovion Respiratory Development General Information
Description
Developer of a pipeline of aerosol drug products for COPD patients. The company focuses on the development of aerosol therapies for patients with respiratory diseases
Contact Information
Website
www.elevationpharma.comCorporate Office
- 11455 El Camino Real
- Suite 460
- San Diego, CA 92130
- United States
Corporate Office
- 11455 El Camino Real
- Suite 460
- San Diego, CA 92130
- United States
Sunovion Respiratory Development Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-Sep-2012 | $100M | Completed | Clinical Trials - Phase 2 | ||
| 2. Early Stage VC (Series B) | 04-Jan-2012 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 26-Sep-2011 | $32.5M | $32.5M | Completed | Product Development |
Sunovion Respiratory Development Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Sunovion Respiratory Development Comparisons
Industry
Financing
Details
Sunovion Respiratory Development Competitors (23)
One of Sunovion Respiratory Development’s 23 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Sunovion Respiratory Development Signals
Sunovion Respiratory Development Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canaan Partners | Venture Capital | Minority | ||
| Care Capital | Venture Capital | Minority | ||
| Catali | Corporation | Minority | ||
| Mesa Verde Venture Partners | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority |
Sunovion Respiratory Development FAQs
-
When was Sunovion Respiratory Development founded?
Sunovion Respiratory Development was founded in 2008.
-
Where is Sunovion Respiratory Development headquartered?
Sunovion Respiratory Development is headquartered in San Diego, CA.
-
What is the size of Sunovion Respiratory Development?
Sunovion Respiratory Development has 7 total employees.
-
What industry is Sunovion Respiratory Development in?
Sunovion Respiratory Development’s primary industry is Drug Discovery.
-
Is Sunovion Respiratory Development a private or public company?
Sunovion Respiratory Development is a Private company.
-
What is the current valuation of Sunovion Respiratory Development?
The current valuation of Sunovion Respiratory Development is .
-
What is Sunovion Respiratory Development’s current revenue?
The current revenue for Sunovion Respiratory Development is .
-
How much funding has Sunovion Respiratory Development raised over time?
Sunovion Respiratory Development has raised $62.5M.
-
Who are Sunovion Respiratory Development’s investors?
Canaan Partners, Care Capital, Catali, Mesa Verde Venture Partners, and Novo Holdings are 5 of 6 investors who have invested in Sunovion Respiratory Development.
-
Who are Sunovion Respiratory Development’s competitors?
Genentech, Pfizer (Vienna), Gesynta Pharma, Ability Pharma, and Merck & Co. are some of the 23 competitors of Sunovion Respiratory Development.
-
When was Sunovion Respiratory Development acquired?
Sunovion Respiratory Development was acquired on 05-Sep-2012.
-
Who acquired Sunovion Respiratory Development?
Sunovion Respiratory Development was acquired by Sunovion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process